Experienced researchers tend to choose based on the specific experimental question
Craving reduction varies widely and is not guaranteed
CV Outcomes in Observational Studies: CVD-REAL Registries In a large multinational study (CVD-REAL [Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors]: 6 European countries and the United States), a treatment with SGLT-2 inhibitors versus other glucose-lowering agents was associated with a lower risk of hospitalization for HF and all-cause death (Table 6)
Its safety profile is excellent, effects are well-documented, and benefits extend beyond physical performance
Cardiovascular toxicology , 17 (4), 482486
We recommend all patients considering taking any oral medications at the same time as semaglutide make decisions cautiously and alongside a healthcare provider. Tirzepatide, marketed as Mounjaro and Zepbound, was a different story